Anticoagulant use for the prevention of stroke in patients with atrial fibrillation: findings from a multi-payer analysis
Open Access
- 28 July 2014
- journal article
- Published by Springer Nature in BMC Health Services Research
- Vol. 14 (1) , 329
Abstract
Oral anticoagulation is recommended for stroke prevention in intermediate/high stroke risk atrial fibrillation (AF) patients. The objective of this study was to demonstrate the usefulness of analytic software tools for descriptive analyses of disease management in atrial AF; a secondary objective is to demonstrate patterns of potential anticoagulant undertreatment in AF.Keywords
This publication has 25 references indexed in Scilit:
- Outpatient red blood cell transfusion payments among patients on chronic dialysisBMC Nephrology, 2012
- Rates and Implications for Hospitalization of Patients ≥65 Years of Age With Atrial Fibrillation/FlutterThe American Journal of Cardiology, 2012
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Guidelines for the Primary Prevention of StrokeStroke, 2011
- Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?The American Journal of Medicine, 2010
- ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults With Nonvalvular Atrial Fibrillation or Atrial FlutterJACC, 2008
- Barriers to Anticoagulation in Patients With Atrial FibrillationStroke, 2008
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- Predictors of Warfarin Use Among Ohio Medicaid Patients With New-Onset Nonvalvular Atrial FibrillationArchives of internal medicine (1960), 2003
- Lifetime Cost of Stroke in the United StatesStroke, 1996